![]() "The industry is too competitive to justify current valuation," he said. Leung has a price target of $96 on the shares, which is about $30 below where they were on Wednesday. "Investor doubts persist around because management is not providing enough high-quality disclosure." ![]() "Overall, while we have issues with management's we continue to believe the business can still exceed short-term guidance given reopening trends and the company's growing scale," he said in a note to clients Thursday. One of those, Howard Leung of Veritas, had a sell recommendation on the company even before Spruce Point levelled its accusations against the company.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |